Healthpeak Properties, Inc. — Wall Street Analyst Estimates & Price Targets

DOC

NYSEReal EstateREIT - Healthcare FacilitiesCIK 0000765880healthpeak.comAbout DOC

Last close · Oct 16, 202618.98+0.02 (+0.11%)

Market cap$13.1B

4 firms' latest targets, last 90 days: median $21.00 ($20.00–$23.00), 11% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker

Each firm's latest target

last 90 days · 4 firms

Date	Firm	Target	Previous	Change	Vs price then	Vs price now
2026-10-13	UBS	$20.00	$19.00	▲ 5%	+6%	+5%
2026-10-13	Barclays	$21.00	$24.00	▼ 12%	+11%	+11%
2026-09-15	Jefferies	$21.00	$17.00	▲ 24%	+3%	+11%
2026-08-06	Cantor Fitzgerald	$23.00	$17.00	▲ 35%	+7%	+21%

Consensus estimates

revenue and EPS by fiscal year · reported years marked

FY	Revenue	YoY	EPS	YoY	Revenue range	EPS range	Analysts
2022reported	$494.9M	+5%	$0.92	-1%	est. $2.0B-76%	est. $1.00	5
2023reported	$527.4M	+7%	$0.56	-39%	est. $2.2B-76%	est. $0.53	8
2024reported	$568.5M	+8%	$0.36	-36%	est. $2.7B-79%	est. $0.40	5
2025reported	$604.0M	+6%	$0.10	-72%	est. $2.8B-78%	est. $0.01	6
2026	$3.0B	+398%	$0.46	+5902%	$3.0B–$3.1B	$0.45–$0.46	5
2027	$3.2B	+7%	$0.22	-52%	$3.1B–$3.3B	$0.21–$0.23	6
2028	$3.5B	+8%	$0.29	+33%	$3.2B–$3.6B	$0.27–$0.31	2
2029	$3.8B	+9%	$0.00	-100%	$3.5B–$3.9B	$0.00–$0.00	4

A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

The analysts at a glance

$21.00median target, 11% above the last close

Firms with a target · last 90 days: 4
Lowest – highest target: $20.00 – $23.00
Current grades of 15 firms: positive / neutral / negative: 4 / 11 / 0
Upgrades / downgrades · 12 months: 0 / 4
Consensus revenue growth · next 3 FY: +79% a year

Current grades

each firm's latest · 15 firms

As of	Firm	Grade
2026-10-13	UBS	“Neutral”
2026-10-13	Barclays	“Equal Weight”
2026-09-21	Evercore ISI	“In Line”
2026-08-13	Baird	“Outperform”
2026-08-11	Citigroup	“Neutral”
2026-08-10	RBC Capital	“Outperform”
2026-08-06	Cantor Fitzgerald	“Neutral”
2026-07-15	Wells Fargo	“Equal Weight”
2026-07-06	Mizuho	“Outperform”
2026-06-24	J.P. Morgan	“Neutral”

5 more

2026-06-15	BMO Capital	“Outperform”
2026-06-11	Morgan Stanley	“Equal Weight”
2026-05-27	Scotiabank	“Sector Perform”
2026-02-05	Argus Research	“Hold”
2025-12-16	Jefferies	“Hold”

Grade changes

last 24 months · 7

Date	Firm	Grade
2026-07-07	Barclays	“Overweight” → “Equal Weight” downgrade
2026-06-11	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2026-02-05	Argus Research	“Buy” → “Hold” downgrade
2025-12-16	Jefferies	“Buy” → “Hold” downgrade
2025-09-15	Raymond James	“Market Perform” → “Outperform” upgrade
2025-08-20	Deutsche Bank	“Buy” → “Hold” downgrade
2025-07-29	Scotiabank	“Sector Outperform” → “Sector Perform” downgrade

46 older than 24 months

2024-05-03	Wedbush	“Neutral” → “Outperform” upgrade
2024-04-01	Bank of America	“Underperform” → “Buy” upgrade
2024-01-12	Scotiabank	“Sector Perform” → “Sector Outperform” upgrade
2024-01-05	Keybanc	“Overweight” → “Sector Weight” downgrade
2023-04-24	Mizuho	“Neutral” → “Buy” upgrade
2023-04-06	Citigroup	“Buy” → “Neutral” downgrade
2023-03-31	Scotiabank	“Sector Outperform” → “Sector Perform” downgrade
2023-01-03	Jefferies	“Hold” → “Buy” upgrade
2022-12-14	RBC Capital	“Outperform” → “Sector Perform” downgrade
2022-12-13	Keybanc	“Sector Weight” → “Overweight” upgrade
2022-11-21	Evercore ISI	“In Line” → “Outperform” upgrade
2022-09-28	Wolfe Research	“Peer Perform” → “Outperform” upgrade
2022-07-08	Citigroup	“Neutral” → “Buy” upgrade
2022-05-19	Bank of America	“Buy” → “Neutral” downgrade
2022-05-18	Bank of America	“Neutral” → “Underperform” downgrade
2022-01-06	BMO Capital	“Outperform” → “Market Perform” downgrade
2021-12-20	J.P. Morgan	“Neutral” → “Overweight” upgrade
2021-08-19	Raymond James	“Outperform” → “Market Perform” downgrade
2021-06-13	Baird	“Outperform” → “Neutral” downgrade
2021-05-20	Berenberg	“Hold” → “Buy” upgrade
2021-05-20	J.P. Morgan	“Overweight” → “Neutral” downgrade
2021-03-30	Bank of America	“Neutral” → “Buy” upgrade
2021-03-14	Morgan Stanley	“Equal Weight” → “Overweight” upgrade
2021-01-12	Jefferies	“Hold” → “Buy” upgrade
2020-12-14	KeyBanc	“Overweight” → “Sector Weight” downgrade
2020-12-10	Wells Fargo	“Equal Weight” → “Underweight” downgrade
2020-11-10	RBC Capital	“Outperform” → “Sector Perform” downgrade
2020-10-16	Mizuho	“Buy” → “Neutral” downgrade
2020-04-29	Raymond James	“Outperform” → “Market Perform” downgrade
2020-03-16	BTIG Research	“Buy” → “Neutral” downgrade
2020-03-08	BMO Capital	“Market Perform” → “Outperform” upgrade
2019-12-11	Citigroup	“Neutral” → “Buy” upgrade
2019-11-26	Stifel	“Hold” → “Buy” upgrade
2019-05-06	BMO Capital	“Outperform” → “Market Perform” downgrade
2019-05-02	Capital One Financial	“Overweight” → “Equal Weight” downgrade
2018-08-03	Capital One Financial	“Overweight” → “Equal Weight” downgrade
2018-04-25	Stifel	“Buy” → “Hold” downgrade
2017-11-05	Hilliard Lyons	“Long Term Buy” → “Buy” revised
2017-10-12	KeyBanc	“Sector Weight” → “Overweight” upgrade
2017-08-20	Jefferies	“Underperform” → “Hold” upgrade
2017-07-23	Morgan Stanley	“Underweight” → “Equal Weight” upgrade
2017-07-06	Jefferies	“Hold” → “Underperform” downgrade
2016-12-16	KeyBanc	“Overweight” → “Sector Weight” downgrade
2016-11-06	Raymond James	“Market Perform” → “Strong Buy” upgrade
2016-06-21	JMP Securities	“Outperform” → “Market Perform” downgrade
2015-12-17	KeyBanc	“Sector Weight” → “Overweight” upgrade

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.